BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 19176510)

  • 1. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
    Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
    Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
    Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
    J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the p53 family in lung cancer.
    Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K
    Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
    Klopfleisch R; Klose P; Gruber AD
    Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p63 normal canine skin and primary cutaneous glandular carcinomas.
    Saraiva AL; Gärtner F; Pires MA
    Vet J; 2008 Jul; 177(1):136-40. PubMed ID: 17804265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors.
    Akiyoshi T; Uchida K; Tateyama S
    Vet Pathol; 2004 Mar; 41(2):154-63. PubMed ID: 15017029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine gastric carcinoma: immunohistochemical expression of cell cycle proteins (p53, p21, and p16) and heat shock proteins (Hsp27 and Hsp70).
    Carrasco V; Canfrán S; Rodríguez-Franco F; Benito A; Sáinz A; Rodríguez-Bertos A
    Vet Pathol; 2011 Jan; 48(1):322-9. PubMed ID: 20587688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p27 expression in canine mammary tumors and their metastases.
    Klopfleisch R; Schütze M; Gruber AD
    Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors.
    Arai K; Nakano H; Shibutani M; Naoi M; Matsuda H
    Vet Pathol; 2003 Nov; 40(6):670-6. PubMed ID: 14608020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
    Gama A; Gärtner F; Alves A; Schmitt F
    Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
    Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
    J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
    Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
    Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
    Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C
    Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.